| Dr Richard Maury Stone, MD | |
|
44 Binney Street, Boston, MA 02115 | |
| (617) 632-2214 | |
| (617) 632-2933 |
| Full Name | Dr Richard Maury Stone |
|---|---|
| Gender | Male |
| Speciality | Hematology/oncology |
| Experience | 43 Years |
| Location | 44 Binney Street, Boston, Massachusetts |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1528036894 | NPI | - | NPPES |
| 3034941 | Other | MASSHEALTH MA MEDICAID | |
| A14180DF | Other | HPHC DFCI ONLY | |
| 8668478 | Other | CIGNA | |
| 2067491 | Other | AETNA US HEALTHCARE | |
| 3004512 | Other | UNITED HEALTH CARE | |
| 37678 | Other | FALLON COMM HEALTH PLAN | |
| 729748 | Other | TUFTS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | 53417 (Massachusetts) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Partners Healthcare At Home - Home Care | Waltham, MA | Home health agency |
| Brigham And Women's Hospital | Boston, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Dana-farber Cancer Institute, Inc. | 9133038904 | 538 |
News Archive
With epidemics of Type 2 diabetes looming in rural India, China and other areas of the world where poverty limits the availability of health care, scientists are reporting development of an inexpensive and easy-to-use urine test ideally suited for such areas. The report describing the paper-based device, which also could be adapted for the diagnosis and monitoring of other conditions and the environment, appears in ACS' journal Analytical Chemistry.
Angiotech Pharmaceuticals has announced that results from the REALITY Trial, a head-to-head trial sponsored by Cordis Corporation, comparing the JNJ CYPHER® stent and the TAXUS® stent, were presented at the American College of Cardiology Annual Scientific Session. The trial failed to meet its primary endpoint.
Endomagnetics, the company developing a portfolio of products to improve the standard of cancer care, has developed a new, higher performance probe for its popular SentiMag instrument.
African leaders participating in the 15th African Union Summit, which concluded on Tuesday, agreed to expand a campaign aimed at curbing maternal mortality on the continent and adopted other "key actions" in an effort to reduce infant and maternal mortality, PANA/Afrique en ligne reports.
› Verified 5 days ago
| Entity Name | Dana-farber Cancer Institute, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346433257 PECOS PAC ID: 9133038904 Enrollment ID: O20040223000142 |
News Archive
With epidemics of Type 2 diabetes looming in rural India, China and other areas of the world where poverty limits the availability of health care, scientists are reporting development of an inexpensive and easy-to-use urine test ideally suited for such areas. The report describing the paper-based device, which also could be adapted for the diagnosis and monitoring of other conditions and the environment, appears in ACS' journal Analytical Chemistry.
Angiotech Pharmaceuticals has announced that results from the REALITY Trial, a head-to-head trial sponsored by Cordis Corporation, comparing the JNJ CYPHER® stent and the TAXUS® stent, were presented at the American College of Cardiology Annual Scientific Session. The trial failed to meet its primary endpoint.
Endomagnetics, the company developing a portfolio of products to improve the standard of cancer care, has developed a new, higher performance probe for its popular SentiMag instrument.
African leaders participating in the 15th African Union Summit, which concluded on Tuesday, agreed to expand a campaign aimed at curbing maternal mortality on the continent and adopted other "key actions" in an effort to reduce infant and maternal mortality, PANA/Afrique en ligne reports.
› Verified 5 days ago
| Entity Name | Dana-farber Cancer Institute, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1851333686 PECOS PAC ID: 9133038904 Enrollment ID: O20040223000228 |
News Archive
With epidemics of Type 2 diabetes looming in rural India, China and other areas of the world where poverty limits the availability of health care, scientists are reporting development of an inexpensive and easy-to-use urine test ideally suited for such areas. The report describing the paper-based device, which also could be adapted for the diagnosis and monitoring of other conditions and the environment, appears in ACS' journal Analytical Chemistry.
Angiotech Pharmaceuticals has announced that results from the REALITY Trial, a head-to-head trial sponsored by Cordis Corporation, comparing the JNJ CYPHER® stent and the TAXUS® stent, were presented at the American College of Cardiology Annual Scientific Session. The trial failed to meet its primary endpoint.
Endomagnetics, the company developing a portfolio of products to improve the standard of cancer care, has developed a new, higher performance probe for its popular SentiMag instrument.
African leaders participating in the 15th African Union Summit, which concluded on Tuesday, agreed to expand a campaign aimed at curbing maternal mortality on the continent and adopted other "key actions" in an effort to reduce infant and maternal mortality, PANA/Afrique en ligne reports.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Richard Maury Stone, MD 11 Juniper Lane, Dover, MA 02030 Ph: (617) 632-2214 | Dr Richard Maury Stone, MD 44 Binney Street, Boston, MA 02115 Ph: (617) 632-2214 |
News Archive
With epidemics of Type 2 diabetes looming in rural India, China and other areas of the world where poverty limits the availability of health care, scientists are reporting development of an inexpensive and easy-to-use urine test ideally suited for such areas. The report describing the paper-based device, which also could be adapted for the diagnosis and monitoring of other conditions and the environment, appears in ACS' journal Analytical Chemistry.
Angiotech Pharmaceuticals has announced that results from the REALITY Trial, a head-to-head trial sponsored by Cordis Corporation, comparing the JNJ CYPHER® stent and the TAXUS® stent, were presented at the American College of Cardiology Annual Scientific Session. The trial failed to meet its primary endpoint.
Endomagnetics, the company developing a portfolio of products to improve the standard of cancer care, has developed a new, higher performance probe for its popular SentiMag instrument.
African leaders participating in the 15th African Union Summit, which concluded on Tuesday, agreed to expand a campaign aimed at curbing maternal mortality on the continent and adopted other "key actions" in an effort to reduce infant and maternal mortality, PANA/Afrique en ligne reports.
› Verified 5 days ago
Kaitlyn My-tu Lam, MBBS Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114 Phone: 617-724-7738 | |
Kui Toh Gerard Leong, M.D. Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 55 Fruit Street, Massachusetts General Hospital, Boston, MA 02114 Phone: 617-726-8862 | |
Ruma Rajbhandari, Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 75 Francis St, Boston, MA 02115 Phone: 617-525-6841 | |
Alaka Ray, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114 Phone: 617-726-2066 | |
Meghan E Sise, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114 Phone: 617-726-2862 | |
Aaron Dickstein, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 800 Washington St, Box 233, Boston, MA 02111 Phone: 617-636-5883 Fax: 617-636-9292 | |
Dr. Felicia Elizabeth Patch, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 801 Massachusetts Ave, Crosstown 2, Boston, MA 02118 Phone: 617-414-4376 Fax: 617-414-4676 |